Shares of Dishman Pharmaceuticals climbed as much as 6 per cent in the early trade on Wednesday after the pharma major issued a clarification on Tuesday (post market hours) regarding a report on the USFDA warning letter to the company for Clovis issue.
In a BSE filing, Dishman Pharma said, “The company has not received any USFDA warnings or any communication whatever due to Clovis issue.”
At 9.32 am, the share price of Dishman Pharmaceuticals was up 5.23 per cent at Rs 342. The scrip opened at Rs 338.60 and had touched a high and low of Rs 344.55 and Rs 327, respectively, in trade so far.
The share price of Dishman Pharmaceuticals and Chemicals fell as much as 16.14 per cent on the BSE on Tuesday